Announced Thu, 3 Sept, 2026 · 17:01 IST
Annual Report FY2025-26 and Notice of 5th AGM
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+7.7%1-day move
₹100.93
prior close
₹105.97
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+7.7+13.1+18.7+23.8+27.3+16.1+17.9+25.2——
Up moveDown movePending
AI summary
Valiant Laboratories filed its Annual Report for FY2025-26 and notice of the 5th AGM on September 28, 2026. Revenue from operations grew 62.7 percent to about 217 crore rupees. PAT swung to a profit of 5.55 crore from a loss of 2.15 crore. EBITDA margin improved to 4.64 percent from 0.56 percent. The 81 crore rupees Rights Issue in August 2025 made the company debt-free. Subsidiary VASPL began commercial output in November 2025.
Likely market impact
Returned to profitability with a debt-free balance sheet, revenue up 62.7 percent, and a new subsidiary in commercial production.